Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-01-27 14:00 |
Kitov Pharma Receives Notice of Intention to Grant European Patent Covering the…
|
English | 38.6 KB | ||
| 2020-01-25 21:29 |
Press Release: Kitov Pharma Receives Notice of Intention to Grant European Pate…
|
English | 163.0 KB | ||
| 2020-01-25 21:29 |
Press Release: Kitov Pharma Receives Notice of Intention to Grant European Pate…
|
English | 38.3 KB | ||
| 2020-01-22 00:32 |
FORM D-Notice of Exempt Offering of Securities
|
English | 154.4 KB | ||
| 2020-01-22 00:32 |
FORM D-Notice of Exempt Offering of Securities
|
English | 38.8 KB | ||
| 2020-01-18 20:59 |
Schedule 13G/A filing with the SEC by EMPERY ASSET MANAGEMENT, LP / EMPERY AM …
|
English | 123.4 KB | ||
| 2020-01-18 20:59 |
Schedule 13G/A filing with the SEC by EMPERY ASSET MANAGEMENT, LP / EMPERY AM …
|
English | 38.1 KB | ||
| 2020-01-09 17:07 |
Kitov Pharma Announces Appointment of Bertrand Liang, M.D., Ph.D., as Chief Med…
|
English | 127.5 KB | ||
| 2020-01-09 17:07 |
Kitov Pharma Announces Appointment of Bertrand Liang, M.D., Ph.D., as Chief Med…
|
English | 38.5 KB | ||
| 2020-01-09 17:00 |
Press Release: Kitov Pharma Announces Appointment of Bertrand Liang, M.D., Ph.D…
|
English | 165.0 KB | ||
| 2020-01-09 17:00 |
Press Release: Kitov Pharma Announces Appointment of Bertrand Liang, M.D., Ph.D…
|
English | 38.2 KB | ||
| 2020-01-08 16:28 |
Kitov Pharma Announces Closing of FameWave Acquisition
|
English | 70.0 KB | ||
| 2020-01-08 16:28 |
Kitov Pharma Announces Closing of FameWave Acquisition
|
English | 41.3 KB | ||
| 2020-01-08 15:44 |
Kitov Pharma Granted Additional 180-day Extension by Nasdaq to Comply with Bid …
|
English | 161.4 KB | ||
| 2020-01-08 15:44 |
Kitov Pharma Granted Additional 180-day Extension by Nasdaq to Comply with Bid …
|
English | 38.8 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
